Skip to main content

LIVE

SI

Shoulder Innovations, Inc.

SI

NYSE·Healthcare·Medical - Specialties·Mkt cap $421.4M

$20.32

-0.34%

P/E

-15.12

Mkt Cap

$421.4M

52-Wk Range

$10.92–$24.60

52-Week Range

$10.92 - $24.60

P/E

-15.12

Fwd P/E

-10.82

Beta

-1.77

Div Yield

0.00%

Avg Vol

111.6K

Shares Out

20.6M

Mkt Cap

$421.4M

Price action

Price chart

Up 27.8% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

3 reasons

  • Proprietary shoulder replacement technology with differentiated design
  • Specialized focus on shoulder joint solutions with deep clinical expertise
  • Experienced founding team with orthopedic industry knowledge

Bear Case

1 risk

  • Low volatility (beta -1.8).

Growth

Moderate growth ahead

Aging global population increasing demand for joint replacement procedures

Value

Trading at 0.0x Medical Devices peers — a discount despite the growth profile.

Momentum

Hot

+43.6% over 3m

Quality

Excellent

Emerging growth company (61% revenue growth). Early stage with higher risk.

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Sep 8, 2026

Q3 26 RECAP

AUG 6, 2026

Reported EPS of -$0.46 vs -$0.46 consensus (-0.3% surprise). Revenue of $17.2M vs $16.6M expected (+3.7%).

EPS miss
Rev beat +3.7%

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-0.3%

Revenue trend · last 8Q

+28%

+41%

+33%

+58%

+65%

+65%

+56%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$7.5M

$8.7M

$10.1M

$11.0M

$11.8M

$14.4M

$16.7M

$17.2M

Margins · last 8Q

Gross

78.3%

Operating

-58.4%

Profit

-59.1%

Wall Street consensus

2 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

2

100%

Hold

0%

Sell

0%

Median Price Target

Latest: UBS · Aug 10, 2026

vs Industry

How SI stacks vs Medical - Specialties

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.